Anti-phospho-Vimentin (Ser72), clone ADE-22

Anti-phospho-Vimentin (Ser72), clone ADE-22
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NSJ-RQ5249 100 µl - -

3 - 10 Werktage*

755,00 €
 
Antibody in PBS with 0.02% sodium azide, 50% glycerol and 0.4-0.5mg/ml BSA. The VIM gene encodes... mehr
Produktinformationen "Anti-phospho-Vimentin (Ser72), clone ADE-22"
Antibody in PBS with 0.02% sodium azide, 50% glycerol and 0.4-0.5mg/ml BSA. The VIM gene encodes a type III intermediate filament protein. Intermediate filaments, along with microtubules and actin microfilaments, make up the cytoskeleton. The encoded protein is responsible for maintaining cell shape and integrity of the cytoplasm, and stabilizing cytoskeletal interactions. This protein is involved in neuritogenesis and cholesterol transport and functions as an organizer of a number of other critical proteins involved in cell attachment, migration, and signaling. [RefSeq] Protein function: Vimentins are class-III intermediate filaments found in various non-epithelial cells, especially mesenchymal cells. Vimentin is attached to the nucleus, endoplasmic reticulum, and mitochondria, either laterally or terminally. [The UniProt Consortium]
Schlagworte: Anti-phospho-VIM, Anti-phospho-Vimentin, Phospho-Vimentin Antibody (pS72)
Hersteller: NSJ Bioreagents
Hersteller-Nr: RQ5249

Eigenschaften

Anwendung: WB
Antikörper-Typ: Monoclonal
Klon: ADE-22
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human
Immunogen: A synthetic peptide specific to human Vimentin (surrounding phosphorylated serine 72)
Format: Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-phospho-Vimentin (Ser72), clone ADE-22"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen